EUVIMEDEUVIMED entdecken
Crossref

Clinicopathological and molecular characterization of seven rare cases of renal cell carcinoma with hemangioblastoma‐like features: Expanding the morphological spectrum of renal tumours with tuberous sclerosis complex/mammalian target of rapamycin mutations

Xuan Tao iD, Xiao-Tong Wang iD, Peng-Cheng Wang iD, Yu-Peng Chen iD, Yi-Juan Wu iD, Qiu-Yuan Xia iD, Qiu Rao iD, Xiao-Ming Qiu iD, Ni Chen iD, Hong Chen iD

Histopathology · 2026

DOI: 10.1111/his.70003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2026. Verfasst von Xuan Tao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Kidney Neoplasms, Carcinoma, Renal Cell, TOR Serine-Threonine Kinases, Hemangioblastoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Fujian Medical University Startup Fund for Scientific Research, Scientific Research Project of National Key Clinical Specialty Construction Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Renal cell carcinoma with hemangioblastoma‐like features (RCC‐HB) is a rare renal cell carcinoma (RCC) subtype. It consists of renal cell carcinoma with fibromyomatous stroma (RCC FMS)‐like and hemangioblastoma (HB)‐like components. However, its molecular characteristics and whether it is a subtype of clear cell renal cell carcinoma (CCRCC), a part of the morphologic spectrum of RCC FMS, or a distinct entity remain unclear. Methods and results We conducted clinicopathological evaluation, immunohistochemistry testing, and next‐generation sequencing (NGS) on seven RCC‐HB cases of tumour tissue, non‐tumour tissue, and blood samples. The cohort included five female and two male patients, aged 33–68 years, with no personal or family history of syndromic disease. Six cases were unifocal, and one was multifocal. Tumours measured 1.2–6.0 cm and were well‐circumscribed by a thick fibrous capsule, with fibromuscular bundles extending into and dividing the lesions. RCC FMS‐like regions resembled CCRCC, RCC FMS, or clear cell papillary renal cell tumour (CCPRCT) and showed CK7 positivity. HB‐like regions featured polygonal or short spindle‐shaped neoplastic stromal cells interspersed with rich capillary networks and were highlighted by S100, α‐inhibin, and GPNMB. DNA sequencing revealed pathogenic variants in MTOR , TSC1 , and TSC2 in six cases, while one case did not detect these gene mutations. All patients were alive without recurrence or metastasis after surgery, with a mean follow‐up of 47.7 months (range: 4–111 months) and a median of 46 months.

Conclusion

This is the largest clinicopathological study to date on RCC‐HB. Our findings support that the vast majority of RCC‐HB harboured TSC/MTOR mutations, different from CCRCC, expanding the morphological spectrum of TSC/MTOR ‐mutated renal tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney NeoplasmsCarcinoma, Renal CellTOR Serine-Threonine KinasesHemangioblastomaHumansFemaleMaleAdultMiddle AgedAgedMutationTuberous SclerosisBiomarkers, Tumor

Stichwörter der Autor:innen

TSC/MTOR mutationsnext‐generation sequencingrenal cell carcinoma with hemangioblastoma‐like features

Substanzen

TOR Serine-Threonine KinasesMTOR protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Department of Pathology, National Regional Medical Center, Binhai Campus of The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
  • Department of Pathology, Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Department of Pathology, Fujian Provincial Hospital, Fuzhou, China.
  • Department of Pathology, Longyan First Hospital, Longyan, China.
  • Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.

ORCID-Profile: Xuan Tao, Xiao-Tong Wang, Peng-Cheng Wang, Yu-Peng Chen, Yi-Juan Wu, Qiu-Yuan Xia, Qiu Rao, Xiao-Ming Qiu, Ni Chen, Hong Chen

Förderung

  • Fujian Medical University Startup Fund for Scientific Research
  • Scientific Research Project of National Key Clinical Specialty Construction Project
  • National Natural Science Foundation of China

Zitieren

APA

Tao, X., Wang, X. T., Wang, P. C., Chen, Y. P., Wu, Y. J., Xia, Q. Y., Rao, Q., Qiu, X. M., Chen, N., & Chen, H. (2026). Clinicopathological and molecular characterization of seven rare cases of renal cell carcinoma with hemangioblastoma‐like features: Expanding the morphological spectrum of renal tumours with tuberous sclerosis complex/mammalian target of rapamycin mutations. Histopathology. https://doi.org/10.1111/his.70003

Vancouver

Tao X, Wang XT, Wang PC, Chen YP, Wu YJ, Xia QY, et al. Clinicopathological and molecular characterization of seven rare cases of renal cell carcinoma with hemangioblastoma‐like features: Expanding the morphological spectrum of renal tumours with tuberous sclerosis complex/mammalian target of rapamycin mutations. Histopathology. 2026. doi:10.1111/his.70003

BibTeX
@article{Tao2026,
  author = {Tao, Xuan and Wang, Xiao-Tong and Wang, Peng-Cheng and Chen, Yu-Peng and Wu, Yi-Juan and Xia, Qiu-Yuan and Rao, Qiu and Qiu, Xiao-Ming and Chen, Ni and Chen, Hong},
  title = {Clinicopathological and molecular characterization of seven rare cases of renal cell carcinoma with hemangioblastoma‐like features: Expanding the morphological spectrum of renal tumours with tuberous sclerosis complex/mammalian target of rapamycin mutations},
  journal = {Histopathology},
  year = {2026},
  doi = {10.1111/his.70003}
}
Kostenlos starten →